Statin-intolerant patients need a different type of clinical trial, Rockefeller researchers say
Thursday, November 17, 2011 - 15:30
in Health & Medicine
Although only five percent of people in clinical trials report side effects from statin drugs, in practice the problem is far greater. Clinical trials need to better address the needs of statin-intolerant patients, Rockefeller researchers say. More »